Medical malpractice in the age of technology: how specialty societies can make a difference.
In the United States, medical malpractice litigation, and the rising cost of malpractice insurance, is a crisis that threatens to restrict patient access to high-risk services, especially obstetrics and certain surgical procedures. Radiation Oncology, though a small specialty, is very technologically oriented. Because the history of product liability and malpractice litigation in this country parallels the technologic revolution, practitioners of this specialty are clearly at risk for litigation. Because legislative relief is unlikely to be forthcoming in the near future, many specialty societies have assumed the responsibility for devising means to protect members from frivolous law suits, without compromising a patient's right to due process. To date, Radiation Oncology societies have not taken a leadership role in this movement, preferring instead to cede this responsibility to the American College of Radiology. Opportunities exist for specialty societies to define standards of care and establish guidelines for expert witness testimony. To date, the courts have been supportive of these efforts. Herein, we summarize some of the salient issues of the malpractice crisis facing Radiation Oncology and offer suggestions for change within the specialty to better address the malpractice problem.
Anscher
Mitchell S
MS
Department of Radiation Oncology, Duke University Medical Center, Durham, NC 27710, USA. ansch001@notes.duke.edu
Anscher
Barbara M
BM
D001918:Brachytherapy; D005104:Expert Testimony; D006801:Humans; D007258:Informed Consent; D008318:Malpractice / Q000331:legislation & jurisprudence; D018787:Radiation Oncology / Q000331:legislation & jurisprudence / Q000592:standards; D012955:Societies, Medical; D013679:Technology, Radiologic / Q000331:legislation & jurisprudence*; D014481:United States